Skip to main content

Advertisement

Log in

Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

Limited data suggest that second resections for colorectal cancer metastases may improve survival, but no study has compared surgery with chemotherapy in this setting. Therefore, we retrospectively compared the clinical outcome of potentially resectable patients who received a second metastasectomy with those who did not in our single-centre experience.

Methods

We retrospectively reviewed the clinical records of all patients treated for metastatic colorectal cancer in our centre over a period of 12 years. We selected patients who relapsed after radical resection of metastases from colorectal cancer and were deemed resectable again by our multidisciplinary team. We then compared the clinical outcome of those who received a second operation with those who refused surgery and also evaluated the role of prognostic factors.

Results

We identified 60 patients fulfilling the inclusion criteria. Twenty-nine underwent a second resection and 31 refused surgery. Median overall survival rates were 58.7 and 24.0 months, median times to progression were 14.4 and 6.6 months. Patients who received surgery plus perioperatory chemotherapy (18/29) had a significantly better outcome; 4/29 achieved long-term disease-free survival.

Conclusions

Our study suggests that in highly selected metastatic colorectal cancer patients, a multimodal treatment plan, including a second resection, can achieve longer survival with respect to medical therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917. doi:10.1002/ijc.25516

    Article  PubMed  CAS  Google Scholar 

  2. Van Cutsem E, Nordlinger B, Cervantes A, Group ESMOGW (2010) Advanced colorectal cancer: ESMO clinical practice guidelines for treatment. Ann Oncol 21(Suppl 5):v93–v97

    Article  PubMed  Google Scholar 

  3. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94:982–999. doi:10.1038/sj.bjc.6603033

    Article  PubMed  CAS  Google Scholar 

  4. Pfannschmidt J, Dienemann H, Hoffmann H (2007) Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 84:324. doi:10.1016/j.athoracsur.2007.02.093

    Article  PubMed  Google Scholar 

  5. Nordlinger B, Vaillant JC, Guiguet M, Balladur P, Paris F, Bachellier P, Jaeck D (1994) Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. L’Association francaise de chirurgie. J Clin Oncol 12:1491–1496

    PubMed  CAS  Google Scholar 

  6. Fernández-Trigo V, Shamsa F, Sugarbaker PH (1995) Repeat liver resections from colorectal metastasis. Repeat hepatic metastases registry. Surgery 117:296–304

    Article  PubMed  Google Scholar 

  7. Adam R, Bismuth H, Castaing D, Waechter F, Navarro F, Abascal A, Majno P, Engerran L (1997) Repeat hepatectomy for colorectal liver metastases. Ann Surg 225:51–60, discussion 60–2

    Article  PubMed  CAS  Google Scholar 

  8. Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Moriya Y, Sugihara K (1999) Repeat liver resection for recurrent colorectal liver metastases. Am J Surg 178:275–281

    Article  PubMed  CAS  Google Scholar 

  9. Petrowsky H, Gonen M, Jarnagin W, Lorenz M, DeMatteo R, Heinrich S, Encke A, Blumgart L, Fong Y (2002) Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 235:863–871

    Article  PubMed  Google Scholar 

  10. Ogata Y, Matono K, Hayashi A, Takamor S, Miwa K, Sasatomi T, Ishibashi N, Shida S, Shirouzu K (2005) Repeat pulmonary resection for isolated recurrent lung metastases yields results comparable to those after first pulmonary resection in colorectal cancer. World J Surg 29:363–368. doi:10.1007/s00268-004-7537-7

    Article  PubMed  Google Scholar 

  11. Nishio H, Hamady ZZR, Malik HZ, Fenwick S, Prasad KR, Toogood GJ, Lodge JPA (2007) Outcome following repeat liver resection for colorectal liver metastases. Eur J Surg Oncol 33:729–734. doi:10.1016/j.ejso.2006.07.005

    Article  PubMed  CAS  Google Scholar 

  12. Welter S, Jacobs J, Krbek T, Krebs B, Stamatis G (2007) Long-term survival after repeated resection of pulmonary metastases from colorectal cancer. Ann Thorac Surg 84:203–210. doi:10.1016/j.athoracsur.2007.03.028

    Article  PubMed  Google Scholar 

  13. Yoshioka K (2002) Kyplot–a user-oriented tool for statistical data analysis and visualization. Comput Stat 17:425–437

    Google Scholar 

  14. Parks R, Gonen M, Kemeny N, Jarnagin W, D’Angelica M, DeMatteo R, Garden OJ, Blumgart LH, Fong Y (2007) Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg 204:753–761. doi:10.1016/j.jamcollsurg.2006.12.036, discussion 761–3

    Article  PubMed  Google Scholar 

  15. Fiorentino F, Hunt I, Teoh K, Treasure T, Utley M (2010) Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis. J R Soc Med 103:60–66. doi:10.1258/jrsm.2009.090299

    Article  PubMed  Google Scholar 

  16. Mahmoud N, Dunn KB (2010) Metastasectomy for stage iv colorectal cancer. Dis Colon Rectum 53:1080–1092. doi:10.1007/DCR.0b013e3181dcadbc

    Article  PubMed  Google Scholar 

  17. Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS, Rivera F, Couture F, Sirzén F, Cassidy J (2008) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase iii study. J Clin Oncol 26:2013–2019. doi:10.1200/JCO.2007.14.9930

    Article  PubMed  CAS  Google Scholar 

  18. Van Cutsem E, Köhne CH, Hitre E, Zaluski J, Chien CRC, Makhson A, D’Haens G, Pintér T, Lim R, Bodoky G, Roh JK, Folprecht G, Ruff P, Stroh C, Tejpar S, Schlichting M, Nippgen J, Rougier P (2009) Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 360:1408–1417. doi:10.1056/NEJMoa0805019

    Article  PubMed  Google Scholar 

  19. Miller G, Biernacki P, Kemeny NE, Gonen M, Downey R, Jarnagin WR, D’Angelica M, Fong Y, Blumgart LH, DeMatteo RP (2007) Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg 205:231–238. doi:10.1016/j.jamcollsurg.2007.04.039

    Article  PubMed  Google Scholar 

  20. Mise Y, Imamura H, Hashimoto T, Seyama Y, Aoki T, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Nakajima J, Kokudo N (2010) Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases. Ann Surg 251:902–909. doi:10.1097/SLA.0b013e3181c9868a

    Article  PubMed  Google Scholar 

  21. D’Angelica M, Kornprat P, Gonen M, Dematteo RP, Fong Y, Blumgart LH, Jarnagin WR (2011) Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases. Ann Surg Oncol 18:1096–1103. doi:10.1245/s10434-010-1409-1

    Article  PubMed  Google Scholar 

  22. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 77:1254–1262

    Article  PubMed  CAS  Google Scholar 

  23. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318, discussion 318–21

    Article  PubMed  CAS  Google Scholar 

  24. Rosen CB, Nagorney DM, Taswell HF, Helgeson SL, Ilstrup DM, van Heerden JA, Adson MA (1992) Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216:493–504, discussion 504–5

    Article  PubMed  CAS  Google Scholar 

  25. Sugihara K, Hojo K, Moriya Y, Yamasaki S, Kosuge T, Takayama T (1993) Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg 80:1032–1035

    Article  PubMed  CAS  Google Scholar 

  26. Scheele J, Stang R, Altendorf-Hofmann A, Paul M (1995) Resection of colorectal liver metastases. World J Surg 19:59–71

    Article  PubMed  CAS  Google Scholar 

  27. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, Yamamoto J, Imamura H (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231:487–499

    Article  PubMed  CAS  Google Scholar 

  28. Ercolani G, Grazi GL, Ravaioli M, Cescon M, Gardini A, Varotti G, Gaudio MD, Nardo B, Cavallari A (2002) Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg 137:1187–1192

    Article  PubMed  Google Scholar 

  29. Nagashima I, Takada T, Matsuda K, Adachi M, Nagawa H, Muto T, Okinaga K (2004) A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg 11:79–83. doi:10.1007/s00534-002-0778-7

    Article  PubMed  Google Scholar 

  30. Reissfelder C, Rahbari NN, Koch M, Ulrich A, Pfeilschifter I, Waltert A, Müller SA, Schemmer P, Büchler MW, Weitz J (2009) Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases. Ann Surg Oncol 16:3279–3288. doi:10.1245/s10434-009-0654-7

    Article  PubMed  Google Scholar 

  31. Keating NL, Landrum MB, Arora NK, Malin JL, Ganz PA, van Ryn M, Weeks JC (2010) Cancer patients’ roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol 28:4364–4370. doi:10.1200/JCO.2009.26.8870

    Article  PubMed  Google Scholar 

  32. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Cutsem EV, Scheithauer W, Gruenberger T, Group EORTCGITC, UK CR, und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO) AL, (AGITG) AGITG, de Cancérologie Digestive (FFCD) FF (2008) Perioperative chemotherapy with folfox4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (eortc intergroup trial 40983): a randomised controlled trial. Lancet 371:1007–1016. doi:10.1016/S0140-6736(08)60455-9

    Article  PubMed  CAS  Google Scholar 

  33. Benoist S, Nordlinger B (2009) The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 16:2385–2390. doi:10.1245/s10434-009-0492-7

    Article  PubMed  Google Scholar 

  34. Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y (2003) Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7:109–115, discussion 116–7

    Article  PubMed  Google Scholar 

  35. Adam R, Wicherts DA, de Haas RJ, Aloia T, Lévi F, Paule B, Guettier C, Kunstlinger F, Delvart V, Azoulay D, Castaing D (2008) Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 26:1635–1641. doi:10.1200/JCO.2007.13.7471

    Article  PubMed  Google Scholar 

  36. Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A (2004) Folfiri followed by folfox6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22:229–237. doi:10.1200/JCO.2004.05.113

    Article  PubMed  CAS  Google Scholar 

  37. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342. doi:10.1056/NEJMoa032691

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giovanni Brandi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brandi, G., Corbelli, J., de Rosa, F. et al. Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. Langenbecks Arch Surg 397, 1069–1077 (2012). https://doi.org/10.1007/s00423-012-0974-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-012-0974-0

Keywords

Navigation